Guided Therapeutics cancels previously approved 1-for-20 reverse stock split, renders amendment void

GUIDED THERAPEUTICS INC

Certificate of Correction filed July 25, 2022, nullifies December 30, 2021 reverse split amendment ab initio.
FINRA never declared the reverse split effective, so it was never implemented on the OTC Market.
Reverse stock split ratio of up to 1-for-20 was approved by stockholders in July 2021 and board in December 2021.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.